Dynamic Technology Lab Private LTD Eagle Pharmaceuticals, Inc. Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$41.26 - $51.35 $316,876 - $394,368	7,680 New	7,680 $341,000
Q2 2021 Aug 13, 2021	SELL	$36.86 - $44.5 $250,721 - $302,689	-6,802 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$40.32 - $50.97 $274,256 - $346,697	6,802 New	6,802 $284,000
Q4 2017 Feb 09, 2018	SELL	$49.6 - $60.87 $213,280 - $261,741	-4,300 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$46.62 - $60.36 $200,466 - $259,548	4,300	4,300 $257,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.